Related Experiment Videos
Recent advances in the treatment of malignant melanoma with gene therapy
1Arizona Cancer Center, Tucson 85724-5024, USA. hersh@azcc.arizona.edu
Molecular Medicine (Cambridge, Mass.)
|December 10, 1997
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Effect of denosumab versus zoledronic acid in preventing skeletal-related events in patients with bone metastases by baseline characteristics.
European journal of cancer (Oxford, England : 1990)·2015
A randomized, controlled phase III trial of nab-Paclitaxel versus dacarbazine in chemotherapy-naïve patients with metastatic melanoma.
Annals of oncology : official journal of the European Society for Medical Oncology·2015
Prevalence of depression in adults with haemophilia.
Haemophilia : the official journal of the World Federation of Hemophilia·2012
Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases.
Annals of oncology : official journal of the European Society for Medical Oncology·2011
Prevalence and risk factors associated with decreased bone mineral density in patients with haemophilia.
Haemophilia : the official journal of the World Federation of Hemophilia·2009
Transduction of human dendritic cells with a recombinant modified vaccinia Ankara virus encoding MUC1 and IL-2.
Cancer immunology, immunotherapy : CII·2001
Short-chain fatty acids as key mediators of the microbiota-gut-brain axis in chronic cerebral hypoperfusion: mechanisms and therapeutics.
Molecular medicine (Cambridge, Mass.)·2026
Urinary collagen type I degradation products as common fibrosis biomarkers in chronic diseases.
Molecular medicine (Cambridge, Mass.)·2026
Proteogenomic Analysis of HDAC4 and HDAC5 in Uveal Melanoma.
Molecular medicine (Cambridge, Mass.)·2026
P1D6 inhibits FnBP-induced extracellular proteome remodeling: proteomic evidence for a novel intervention strategy in atopic dermatitis.
Molecular medicine (Cambridge, Mass.)·2026
WHAMM deficiency alters splenic B-cell populations, BCR signaling, and actin remodeling.
Molecular medicine (Cambridge, Mass.)·2026
Drugs inducing interstitial lung disease: in silico analysis of their structures and targets.
Molecular medicine (Cambridge, Mass.)·2026
APOBEC3 Knockout in Lentiviral Packaging Cells Improves Therapeutic Transgene Sequence Fidelity.
Molecular therapy : the journal of the American Society of Gene Therapy·2026
PRDM16 as a Multifaceted Pharmacological Target in Kidney Diseases: From Epigenetic Mechanisms to Therapeutic Strategies.
Pharmaceuticals (Basel, Switzerland)·2026
Olmesartan-Loaded PLGA Nanoparticles Attenuate Methotrexate-Induced Kidney Injury: Association with the AT1R/ERK1/2 Signaling Axis.
Pharmaceuticals (Basel, Switzerland)·2026